Agnieszka Boesen

Array ( [id] => 5834591 [patent_doc_number] => 20060246421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Compounds and methods for inhibiting hepatitis C virus replication' [patent_app_type] => utility [patent_app_number] => 11/119587 [patent_app_country] => US [patent_app_date] => 2005-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 20228 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246421.pdf [firstpage_image] =>[orig_patent_app_number] => 11119587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550556 [patent_doc_number] => 08062888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'High throughput assays for transmissible spongiform encephalopathies (TSE)' [patent_app_type] => utility [patent_app_number] => 11/114411 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8648 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/062/08062888.pdf [firstpage_image] =>[orig_patent_app_number] => 11114411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739495 [patent_doc_number] => 20080233148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Method of Producing Virus' [patent_app_type] => utility [patent_app_number] => 10/587431 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10008 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233148.pdf [firstpage_image] =>[orig_patent_app_number] => 10587431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793532 [patent_doc_number] => 20060014213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies' [patent_app_type] => utility [patent_app_number] => 11/108118 [patent_app_country] => US [patent_app_date] => 2005-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2532 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014213.pdf [firstpage_image] =>[orig_patent_app_number] => 11108118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865479 [patent_doc_number] => 20060099609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Activation of natural killer (NK) cells and methods of use' [patent_app_type] => utility [patent_app_number] => 11/105056 [patent_app_country] => US [patent_app_date] => 2005-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16214 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099609.pdf [firstpage_image] =>[orig_patent_app_number] => 11105056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069040 [patent_doc_number] => 20050244423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Methods for treating viral infection using IL-28 and IL-29 cysteine mutants' [patent_app_type] => utility [patent_app_number] => 11/098662 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39388 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244423.pdf [firstpage_image] =>[orig_patent_app_number] => 11098662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820381 [patent_doc_number] => 20060024694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Cellular targets for treatment of retroviral infection' [patent_app_type] => utility [patent_app_number] => 11/093692 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15707 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024694.pdf [firstpage_image] =>[orig_patent_app_number] => 11093692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5800105 [patent_doc_number] => 20060035242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Prion-specific peptide reagents' [patent_app_type] => utility [patent_app_number] => 11/056950 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34549 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035242.pdf [firstpage_image] =>[orig_patent_app_number] => 11056950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110618 [patent_doc_number] => 20050208073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Vaccine against feline calicivirus' [patent_app_type] => utility [patent_app_number] => 11/040670 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13261 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208073.pdf [firstpage_image] =>[orig_patent_app_number] => 11040670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110618 [patent_doc_number] => 20050208073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Vaccine against feline calicivirus' [patent_app_type] => utility [patent_app_number] => 11/040670 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13261 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208073.pdf [firstpage_image] =>[orig_patent_app_number] => 11040670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119991 [patent_doc_number] => 20070141705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Method for producing viral vectors' [patent_app_type] => utility [patent_app_number] => 10/587123 [patent_app_country] => US [patent_app_date] => 2005-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24810 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141705.pdf [firstpage_image] =>[orig_patent_app_number] => 10587123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502149 [patent_doc_number] => 20090162837 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2009-06-25 [patent_title] => 'Inactivated FCV vaccines' [patent_app_type] => utility [patent_app_number] => 11/038682 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7720 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0162/20090162837.pdf [firstpage_image] =>[orig_patent_app_number] => 11038682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502149 [patent_doc_number] => 20090162837 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2009-06-25 [patent_title] => 'Inactivated FCV vaccines' [patent_app_type] => utility [patent_app_number] => 11/038682 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7720 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0162/20090162837.pdf [firstpage_image] =>[orig_patent_app_number] => 11038682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502149 [patent_doc_number] => 20090162837 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2009-06-25 [patent_title] => 'Inactivated FCV vaccines' [patent_app_type] => utility [patent_app_number] => 11/038682 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7720 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0162/20090162837.pdf [firstpage_image] =>[orig_patent_app_number] => 11038682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6944701 [patent_doc_number] => 20050196750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Determination of hepatitis C virus genotype' [patent_app_type] => utility [patent_app_number] => 11/031487 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17916 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20050196750.pdf [firstpage_image] =>[orig_patent_app_number] => 11031487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119360 [patent_doc_number] => 20070141074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Agents for the inhibition of virus replication through regulation of protein folding' [patent_app_type] => utility [patent_app_number] => 10/584934 [patent_app_country] => US [patent_app_date] => 2004-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6232 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141074.pdf [firstpage_image] =>[orig_patent_app_number] => 10584934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069122 [patent_doc_number] => 20050244505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Immunotherapy compositions, method of making and method of use thereof' [patent_app_type] => utility [patent_app_number] => 11/008936 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 17318 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244505.pdf [firstpage_image] =>[orig_patent_app_number] => 11008936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7111026 [patent_doc_number] => 20050208481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Diagnostic device using GP40' [patent_app_type] => utility [patent_app_number] => 10/995847 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6982 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208481.pdf [firstpage_image] =>[orig_patent_app_number] => 10995847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7601653 [patent_doc_number] => 07385049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-10 [patent_title] => 'Oligonucleotides and methods for detection of West Nile virus' [patent_app_type] => utility [patent_app_number] => 10/985805 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 1 [patent_no_of_words] => 10793 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/385/07385049.pdf [firstpage_image] =>[orig_patent_app_number] => 10985805 [rel_patent_id] =>[rel_patent_doc_number] =>)